Difluprednate Matches Prednisolone Acetate for Cataract Removal Inflammation Control
Investigators compare difluprednate 0.05% nanoemulsion twice a day with prednisolone acetate dosed 4 times a day.
Investigators compare difluprednate 0.05% nanoemulsion twice a day with prednisolone acetate dosed 4 times a day.
Infection rates have increased since the start of the COVID-19 pandemic, with the largest rise seen in patients who underwent vitrectomy without cataract surgery.
Investigators did not observe cystoid macular edema or vitreous hemorrhage in the cohort, which often occurs in patients with other forms of intermediate uveitis.
The findings may help identify predictive biomarkers or pharmacological interventions for glaucoma.
Both children infected and their parents or caretakers demonstrated a significantly lowered emotional functioning, researchers report.
Significant associations observed between vision impairment and cognitive outcomes of cognitive impairment and dementia
Among patients with noninfectious uveitis, systemic corticosteroid use may increase risk for COVID-19 infection and related severe outcomes, a study suggests.
Children exposed to SARS-CoV-2 who developed Multisystemic Inflammatory Syndrome (MIS-C) present with specific retinal microvascular changes, a study shows.
A study shows significantly reduced posterior stromal keratocyte density and other changes following SARS-CoV-2 infection.
Cytomegalovirus and Varicella Zoster Virus-Related Uveitic Secondary Glaucoma.